tDCS for Cognitive Issues in Breast Cancer Survivors
tDCS Intervention in Breast Cancer Survivors With and Without Obesity Reporting Cognitive Impairment
Recruiting
N/A
Interventional Study
Breast Cancer Survivor
Obesity, Overweight
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Interventional
- Purpose
- Basic Science
- Participants needed
- 40 (estimated)
- Sponsor
- University of Helsinki · Other
Who this trial is looking for
This trial is looking for women who have survived breast cancer and may be experiencing cognitive problems. Participants will receive a specific type of brain stimulation for six weeks and undergo various tests to see how it affects their thinking.
Are You a Good Fit for This Trial?
You may be able to join if
- I am female
- I am over 18 years old
- I was diagnosed with breast cancer in the last 5 years
- I have completed all my cancer treatments at least 3 months ago
- I can meet study requirements and have internet access
- I speak either Finnish or English
- I have normal or corrected vision and hearing
- I am right-handed
You may not be able to join if
- I have received cancer treatment in the last 3 months
- I have a history of childhood-onset cancer
- I have acute eczema on my scalp
- I have been diagnosed with dementia or other serious brain conditions
- I have lost consciousness for more than five minutes due to a brain injury in the last 10 years
- I have a history of stroke
- I suffer from claustrophobia
- I am pregnant or breastfeeding
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this intervention is to investigate whether transcranial Direct Current Stimulation (tDCS) can alleviate Cancer-Related Cognitive Impairment (CRCI) in breast cancer survivors, as measured by changes in brain structures and cognitive performance. To assess the efficacy of tDCS, the investigators will compare outcomes between participants receiving active stimulation and those receiving …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Female
* Over 18 years old
* Diagnosed with primary adult-onset breast cancer within the last 5 years
* Completed all active cancer treatments at least 3 months prior to study participation
* Capable of fulfilling study requirements, including having internet access.
* Fluent …
Contacts